305 related articles for article (PubMed ID: 15743427)
1. A novel mycological analysis valuable for evaluating therapeutic efficacy of antimycotics against experimental dermatophytosis in guinea pigs.
Majima T; Masui S; Uchida K; Yamaguchi H
Mycoses; 2005 Mar; 48(2):108-13. PubMed ID: 15743427
[TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
[TBL] [Abstract][Full Text] [Related]
3. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
[TBL] [Abstract][Full Text] [Related]
4. Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model.
Ghannoum MA; Long L; Pfister WR
Mycoses; 2009 Jan; 52(1):35-43. PubMed ID: 18498299
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antidermatophytic activity of saperconazole, a new fluorinated triazole.
Fu KP; Isaacson DM; Lococo J; Foleno B; Hilliard J
Drugs Exp Clin Res; 1992; 18(11-12):443-6. PubMed ID: 1308468
[TBL] [Abstract][Full Text] [Related]
6. In vivo fungicidal effect of KP-103 in a guinea pig model of interdigital tinea pedis determined by using a new method for removing the antimycotic carryover effect.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Microbiol Immunol; 2002; 46(7):433-9. PubMed ID: 12222929
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs.
Oka H; Niwano Y; Ohmi T; Tanaka T; Uchida M; Yamaguchi H
Arzneimittelforschung; 1992 Mar; 42(3):345-9. PubMed ID: 1497697
[TBL] [Abstract][Full Text] [Related]
8. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis.
Uchida K; Tanaka T; Yamaguchi H
Microbiol Immunol; 2003; 47(2):143-6. PubMed ID: 12680717
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antifungal efficacy in an optimized animal model of Trichophyton mentagrophytes-dermatophytosis.
Ghannoum MA; Hossain MA; Long L; Mohamed S; Reyes G; Mukherjee PK
J Chemother; 2004 Apr; 16(2):139-44. PubMed ID: 15216947
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of AS2077715 against experimental tinea pedis in guinea pigs in comparison with terbinafine.
Ohsumi K; Murai H; Nakamura I; Watanabe M; Fujie A
J Antibiot (Tokyo); 2014 Oct; 67(10):717-9. PubMed ID: 24865864
[TBL] [Abstract][Full Text] [Related]
11. Anti-dermatophytic activity of bakuchiol: in vitro mechanistic studies and in vivo tinea pedis-inhibiting activity in a guinea pig model.
Lau KM; Wong JH; Wu YO; Cheng L; Wong CW; To MH; Lau CP; Yew DT; Leung PC; Fung KP; Hui M; Ng TB; Lau CB
Phytomedicine; 2014 Jun; 21(7):942-5. PubMed ID: 24703327
[TBL] [Abstract][Full Text] [Related]
12. An in vitro human skin model for assaying topical drugs against dermatophytic fungi.
Kligman AM; McGinley KJ; Foglia A
Acta Derm Venereol; 1987; 67(3):243-8. PubMed ID: 2442938
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
Tatsumi Y; Yokoo M; Senda H; Kakehi K
Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of oral treatment with terbinafine in a guinea pig model of tinea pedis].
Uchida K; Yamaguchi H
Jpn J Antibiot; 1994 Oct; 47(10):1401-6. PubMed ID: 7807699
[TBL] [Abstract][Full Text] [Related]
15. Activity of terbinafine on Trichophyton mentagrophytes in a human living skin equivalent model.
Rashid A; Edward M; Richardson MD
J Med Vet Mycol; 1995; 33(4):229-33. PubMed ID: 8531020
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models.
Wakabayashi H; Uchida K; Yamauchi K; Teraguchi S; Hayasawa H; Yamaguchi H
J Antimicrob Chemother; 2000 Oct; 46(4):595-602. PubMed ID: 11020258
[TBL] [Abstract][Full Text] [Related]
17. KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigs.
Tatsum Y; Yokoo M; Arika T; Yamaguchi H
Microbiol Immunol; 2002; 46(7):425-32. PubMed ID: 12222928
[TBL] [Abstract][Full Text] [Related]
18. What defines the quality of patient care in tinea pedis?
Mistik S; Ferahbas A; Koc AN; Ayangil D; Ozturk A
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of omoconazole nitrate on experimental tinea pedis, an intractable dermatophytosis, in guinea-pigs.
Itoyama T; Uchida K; Yamaguchi H; Fujita S
J Antimicrob Chemother; 1997 Sep; 40(3):441-4. PubMed ID: 9338501
[TBL] [Abstract][Full Text] [Related]
20. Efficacy testing of antimycotic prophylactics in an animal model.
Treiber A; Pittermann W; Schuppe HC
Int J Hyg Environ Health; 2001 Dec; 204(4):239-43. PubMed ID: 11833296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
